Update on Psoriasis by the International Psoriasis Council

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

What's New

Psoriasis and Metabolic Health: What IPC’s Latest Publication Means for Clinical Practice

A new IPC paper in JAAD presents five priorities for improving metabolic screening, advancing GLP-1 research in the context of psoriasis, and defining the dermatologist’s role in managing cardiometabolic risk in psoriasis patients.

Wednesday, July 29, 2026

Challenging Patient Interactions: What’s Really Behind the ‘Difficult’ Label — A Conversation with Dr. John Koo

IPC Jr. Councilor Mio Nakamura speaks with Dr. John Koo about how personality traits, including borderline personality disorder, shape clinical interactions and shares practical strategies for dermatologists to build stronger patient relationships.

Monday, July 27, 2026

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.

WATCH NOW

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.

WATCH NOW

Thursday, July 13, 2026

A New Genetic Clue in Psoriasis: What the ADAR1 Discovery Means

Rare ADAR1 gene mutations drive a distinct, interferon-fueled psoriasis subtype, and it responds to JAK1 and TYK2 inhibitors rather than standard IL-17/IL-23 biologics.

Wednesday, July 15, 2026

New Take Tens on Psoriatic Arthritis

IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.

IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.

WATCH NOW

Advancing Knowledge. Improving Care.

Update on Psoriasis by the International Psoriasis Council

VIRTUAL

Agenda

Program Chair

Rudi Chandra, MD

University of Prima – Medan

Medan, North Sumatera, Indonesia

IPC Jr. Councilor

Program Faculty

Siew Eng Choon, MBBS, FRCP

Hospital Sultanah Aminah Johor Bahru, Clinical School Johor Bahru, Jeffrey Cheah School of Medicine and Health Services, Monash University Malaysia

Johor, Malaysia

IPC Board Member

Curdin Conrad, MD

University Hospital of Lausanne

Lausanne, Switzerland

IPC Board Member

Tiago Torres, MD, PhD

Centro Hospitalar Universitário de Santo António, University of Porto

Porto, Portugal

IPC Councilor

Quick Links

Follow us

Psoriasis and Metabolic Health: What IPC’s Latest Publication Means for Clinical Practice

Challenging Patient Interactions: What’s Really Behind the ‘Difficult’ Label — A Conversation with Dr. John Koo

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

Thursday, July 13, 2026

A New Genetic Clue in Psoriasis: What the ADAR1 Discovery Means

New Take Tens on Psoriatic Arthritis

Wednesday, July 8, 2026